Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
Medicare now covers renal denervation for patients with uncontrolled hypertension
This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.

Researchers recommend a more comprehensive evaluation of respiratory function in AFib patients.

In addition, researchers noted, there were no female specialists performing TAVR in 19 states.

When hospitalized heart failure patients also have cirrhosis of the liver, they may require "increased resources to assist in caring for them."

The device was designed to treat patients facing a heightened risk of recurrent stroke.

The approval comes as more and more specialists embrace a radial-first approach to treating acute coronary syndrome.

The new study examines yet another way the pandemic impacted cardiovascular care.

“The choice of intervention in patients with CKD and aortic stenosis is complex and influenced by multiple competing factors," researchers said.

Closer monitoring for uncontrolled hypertension is recommended for women ages 70 and older and men under the age of 50.